🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Bladder cancer is the seventh most common cancer in the UK, with 10,399 new...
Status
Active Not Recruiting
Location
Riverina Cancer Care Centre
Start Date
2015-10-21
Trial ID
NCT02447549
At the moment there is a lack of data in the setting of oligometastatic PC ...
Status
Active Not Recruiting
Location
Humanitas Research Hospital
Start Date
2020-10-19
Trial ID
NCT04624828
Treatments Being Tested
SBRT delivers high-dose radiation to precisely defined target volumes and i...
Status
Recruiting
Location
University Hospital Zurich
Start Date
2026-06-16
Trial ID
NCT07687147
Treatments Being Tested
The study aimed for: 1. Comparative evaluation of the safety of the drug M...
Status
Completed
Location
Limited Liability Company "Research Center Eco-Safety"
Start Date
2022-04-22
Trial ID
NCT05412173
Treatments Being Tested
This Phase II, single arm study evaluates a PSA-response-adapted approach t...
Status
Recruiting
Location
UT Southwestern Medical Center-Dallas
Start Date
2025-11-14
Trial ID
NCT07313241
Treatments Being Tested
This phase II trial studies how well using circulating tumor deoxyribonucle...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2024-03-21
Trial ID
NCT06323460
This Phase 1 trial aimed to determine the maximum tolerated fraction dose (...
Status
Completed
Location
Sun yat-sen University Cancer Center
Start Date
2021-06-01
Trial ID
NCT04951063
Treatments Being Tested
In 2018 the Unity MR-linac was approved for treating patients with online m...
Status
Completed
Location
Odense University Hospital
Start Date
2020-11-19
Trial ID
NCT05615909
Treatments Being Tested
This is a randomized, single centre, single blinded prospective study compa...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2025-10-15
Trial ID
NCT07348887
Treatments Being Tested
This Phase III trial aims to: Explore the impact of pre-treatment informat...
Status
Completed
Location
Gustave Roussy Cancer Institute
Start Date
2012-09-07
Trial ID
NCT01504815
Treatments Being Tested